CME Group Total Equity decreased by 7.3% to $26.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $27.03B to $26.62B. Over 5 years (FY 2020 to FY 2025), Total Equity shows relatively stable performance with a 1.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A growing equity base suggests increasing value for shareholders, though aggressive share buybacks can intentionally reduce this figure.
The residual interest in the assets of the company after deducting all liabilities. It represents the net book value of...
Used to calculate Return on Equity (ROE), a primary measure of how effectively management is using shareholder capital to generate profit.
total_stockholders_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.76B | $27.28B | $27.40B | $27.74B | $28.00B | $28.25B | $26.88B | $27.38B | $27.82B | $28.15B | $26.74B | $27.15B | $27.64B | $28.22B | $26.49B | $27.03B | $27.74B | $28.19B | $28.73B | $26.62B |
| QoQ Change | — | +1.9% | +0.4% | +1.2% | +1.0% | +0.9% | -4.9% | +1.9% | +1.6% | +1.2% | -5.0% | +1.6% | +1.8% | +2.1% | -6.1% | +2.1% | +2.6% | +1.6% | +1.9% | -7.3% |
| YoY Change | — | — | — | — | +4.6% | +3.6% | -1.9% | -1.3% | -0.7% | -0.4% | -0.5% | -0.8% | -0.7% | +0.2% | -0.9% | -0.5% | +0.4% | -0.1% | +8.5% | -1.5% |